2004D-0493 - Guidance for Industry: Recommended Approaches to Integration of Genetic Toxicology Study Results
FDA Comment Number : EC1
Submitter : Mrs. Anne Stokley, MSPH Date & Time: 02/08/2005 06:02:06
Organization : GlaxoSmithKline
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
See Attachment